Rare diseases
Investigational molecules
Locations
Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
FranceStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
BelgiumStudy of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer
FranceStudy on the Effects of MYK-224 for Patients with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
ItalyComparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety
FranceStudy on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis
GermanyStudy on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
CzechiaStudy on the Long-Term Safety of Alpelisib for Patients with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceStudy Comparing Cisplatin and Radiotherapy with Durvalumab and Radiotherapy for Patients with Intermediate Risk HPV-Positive Oropharyngeal Cancer
BelgiumStudy on the Safety of Allocetra for Patients with Knee Osteoarthritis
DenmarkStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
BelgiumStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
